Related Experiment Video

Updated: Dec 28, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

681

MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation

Yanlong Wang1, Jiyu Yang1, Pangtao Chen1

  • 1Departments of Orthopedic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P.R. China.

Cancer Medicine
|February 18, 2020
PubMed

Insights

MicroRNA-320a acts as a tumor suppressor in osteosarcoma by downregulating CPEB1. This finding suggests miR-320a as a potential therapeutic target for osteosarcoma progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a common bone cancer in young individuals.
  • MicroRNAs (miRNAs) are known to be dysregulated in various cancers.
  • The specific role of miR-320a in osteosarcoma remains largely unexplored.

Purpose of the Study:

  • To investigate the function of miR-320a in osteosarcoma.
  • To identify the molecular targets of miR-320a in osteosarcoma cells.
  • To explore the potential of miR-320a as a therapeutic target for osteosarcoma.

Main Methods:

  • Overexpression of miR-320a and knockdown of cytoplasmic polyadenylation element-binding protein 1 (CPEB1) in osteosarcoma cells.
  • Analysis of cell migration and invasion.
  • Luciferase reporter assays to confirm direct targeting of CPEB1 by miR-320a.
  • Reintroduction of CPEB1 to assess its effect on miR-320a functions.

Main Results:

  • Overexpression of miR-320a inhibited osteosarcoma cell migration and invasion.
  • Knockdown of CPEB1 also inhibited osteosarcoma cell migration and invasion.
  • miR-320a directly targets the 3'-UTR of CPEB1, leading to its downregulation.
  • Reintroduction of CPEB1 reversed the anti-proliferative, anti-migratory, and anti-invasive effects of miR-320a.

Conclusions:

  • miR-320a functions as a tumor suppressor in osteosarcoma.
  • The tumor-suppressive role of miR-320a is mediated through the downregulation of CPEB1.
  • miR-320a represents a potential therapeutic target for osteosarcoma treatment.
Keywords:
cytoplasmic polyadenylation element-binding protein 1miR-320amicroRNAsosteosarcoma

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

17.9K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K